Stockscreener 앱 받기
8.735
2.07%
0.175
Ars Pharmaceuticals Inc 주식(SPRY)의 최신 뉴스
How The ARS Pharmaceuticals (SPRY) Narrative Is Shifting With Fresh Analyst Models And Approvals - Yahoo Finance
SPRY Stock Price, Quote & Chart | ARS PHARMACEUTICALS INC (NASDAQ:SPRY) - ChartMill
[ARS] SUPERNUS PHARMACEUTICALS, INC. SEC Filing - Stock Titan
[ARS] Eledon Pharmaceuticals, Inc. SEC Filing - Stock Titan
[ARS] Zentalis Pharmaceuticals, Inc. SEC Filing - Stock Titan
[ARS] RECURSION PHARMACEUTICALS, INC. SEC Filing - Stock Titan
[ARS] Milestone Pharmaceuticals Inc. SEC Filing - Stock Titan
[ARS] Olema Pharmaceuticals, Inc. SEC Filing - Stock Titan
[ARS] RHYTHM PHARMACEUTICALS, INC. SEC Filing - Stock Titan
[ARS] ARS Pharmaceuticals, Inc. SEC Filing - Stock Titan
ARS Pharmaceuticals (NASDAQ: SPRY) sets 2026 meeting, highlights neffy launch and cash runway - Stock Titan
[ARS] MADRIGAL PHARMACEUTICALS, INC. SEC Filing - Stock Titan
[ARS] IRONWOOD PHARMACEUTICALS INC SEC Filing - Stock Titan
[ARS] Oric Pharmaceuticals, Inc. SEC Filing - Stock Titan
ARS Pharmaceuticals, Inc. (SPRY) soars 7.1%: Is further upside left in the stock? - MSN
BlackRock (SPRY) files amendment showing 4.98% ownership - Stock Titan
Epinephrine Nasal Spray Approved for Severe Allergic Reactions in EU - respiratory-therapy.com
Avoiding Lag: Real-Time Signals in (SPRY) Movement - Stock Traders Daily
[ARS] REGENERON PHARMACEUTICALS, INC. SEC Filing - Stock Titan
[ARS] AGIOS PHARMACEUTICALS, INC. SEC Filing - Stock Titan
[ARS] BridgeBio Pharma, Inc. SEC Filing - Stock Titan
ARS Pharmaceuticals Q3 2025 Earnings Preview - MSN
[ARS] Vanda Pharmaceuticals Inc. SEC Filing - Stock Titan
[ARS] Acumen Pharmaceuticals, Inc. SEC Filing - Stock Titan
[ARS] LB PHARMACEUTICALS INC SEC Filing - Stock Titan
[ARS] IONIS PHARMACEUTICALS INC SEC Filing - Stock Titan
[ARS] BIOCRYST PHARMACEUTICALS INC SEC Filing - Stock Titan
ARS Pharmaceuticals, Inc. (SPRY) Soars 7.1%: Is Further Upside Left in the Stock? - Yahoo Finance
[ARS] Amylyx Pharmaceuticals, Inc. SEC Filing - Stock Titan
[ARS] Xenon Pharmaceuticals Inc. SEC Filing - Stock Titan
FDA Approves Neffy Needle-Free Epinephrine Nasal Spray for Younger Children - respiratory-therapy.com
[ARS] PMV Pharmaceuticals, Inc. SEC Filing - Stock Titan
[ARS] LIGAND PHARMACEUTICALS INC SEC Filing - Stock Titan
[ARS] Shuttle Pharmaceuticals Holdings, Inc. SEC Filing - Stock Titan
[ARS] Verrica Pharmaceuticals Inc. SEC Filing - Stock Titan
FDA Approves Expanded Use for ARS Pharmaceuticals Nasal Spray - HarianBasis.co
Northland Highlights ARS Pharmaceuticals, Inc. (SPRY) Needle-Free Therapy as Major Innovation Driver - Insider Monkey
Pharma-Bio Serv (PBSV) posts $9.0M revenue, margins lift in Europe - Stock Titan
ARS Pharmaceuticals (SPRY) Stock: Breakdown Signals (Nudges Up) 2026-04-16Social Momentum Signals - UBND thành phố Hải Phòng
neffy® (epinephrine nasal spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis) - Sahm
neffy® Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions - Investing News Network
Health Canada approves neffy nasal spray for severe allergies By Investing.com - Investing.com Australia
William Blair Maintains ARS Pharmaceuticals(SPRY.US) With Buy Rating - Moomoo
Health Canada approves neffy nasal spray for severe allergies - Investing.com
Health Canada Approves neffy Nasal Spray for Anaphylaxis Treatment in Canada, Available Summer 2026 - Quiver Quantitative
neffy® (epinephrine nasal spray) Approved in Canada as the - GlobeNewswire
Discipline and Rules-Based Execution in SPRY Response - Stock Traders Daily
[ARS] Amphastar Pharmaceuticals, Inc. SEC Filing - Stock Titan
Q1 Earnings Forecast for SPRY Issued By Northland Securities - MarketBeat
Rally Mode: Can ARS Pharmaceuticals Inc sustain earnings growth2026 Reactions & Community Trade Idea Sharing Platform - baoquankhu1.vn
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
ARS Pharmaceuticals (NASDAQ:SPRY) Coverage Initiated by Analysts at Northland Securities - MarketBeat
Winners Losers: Whats ARS Pharmaceuticals Incs historical returnTrade Entry Summary & Proven Capital Preservation Tips - baoquankhu1.vn
Northland initiates ARS Pharmaceuticals stock with outperform rating By Investing.com - Investing.com Canada
0.83%
0.61%
자본화:
|
볼륨(24시간):